0
Your cart

Your cart is empty

Browse All Departments
Price
  • R100 - R250 (17)
  • R250 - R500 (65)
  • R500+ (186)
  • -
Status
Format
Author / Contributor
Publisher

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy

Chemosensitivity Testing in Oncology (Hardcover, 2003 ed.): Uwe Reinhold, Wolfgang Tilgen Chemosensitivity Testing in Oncology (Hardcover, 2003 ed.)
Uwe Reinhold, Wolfgang Tilgen
R4,377 Discovery Miles 43 770 Ships in 10 - 15 working days

The last decade has seen a renaissance of the concept of individualized chemotherapy in oncology, markedly stimulated by the development of new in vitro chemosensitivity assays. The clinical utility of drug response assays has been evaluated in clinical trials and the results suggest that assay-assisted therapy selection may improve survival as well as economic outcomes. This volume comprises the proceedings of the first Symposium of the International Society for Chemosensitivity Testing in Oncology, ISCO-1, held in Homburg/Saar, Germany, in September 2001. The topics include: new in vitro drug-testing methods, tumor chemosensitivity assays, and the clinical relevance of assay-directed therapy.

Antibody-Drug Conjugates (Hardcover, 2013 ed.): Laurent Ducry Antibody-Drug Conjugates (Hardcover, 2013 ed.)
Laurent Ducry
R5,479 R5,132 Discovery Miles 51 320 Save R347 (6%) Ships in 12 - 19 working days

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. In Antibody-Drug Conjugates, expert researchers provide detailed protocols for many of the key ADC techniques necessary for working in the field. These chapters and methodologies are aimed at the key tasks necessary to identify a suitable target, properly design the mAb, the linker and the payload, as well as to conjugate them in a reproducible and scalable fashion. Written in the highly successful Methods in Molecular Biology (TM) format, these detailed chapters include the kind of practical implementation advice that guarantees quality results. Authoritative and timely, Antibody-Drug Conjugates aims to further drive ADC development and thus help toward improving cancer treatments of the future.

Antimalarial Chemotherapy - Mechanisms of Action, Resistance, and New Directions in Drug Discovery (Hardcover, 2001 ed.):... Antimalarial Chemotherapy - Mechanisms of Action, Resistance, and New Directions in Drug Discovery (Hardcover, 2001 ed.)
Philip J. Rosenthal
R5,697 Discovery Miles 56 970 Ships in 10 - 15 working days

Philip Rosenthal, MD, and a panel of leading malaria experts drawn from academia, the military, and international health organizations survey the latest scientific understanding of antimalarial chemotherapy, emphasizing the molecular mechanisms of resistance and the description of important new targets. Their survey covers the current status of malarial and antimalarial chemotherapy, the relevant biology and biochemistry of malaria parasites, the antimalarial drugs currently available, new chemical approaches to chemotherapy, and possible new targets for chemotherapy. Comprehensive and cutting-edge, Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery clearly delineates all the basic and clinical research now addressing one of the world's major unresolved disease problems, work that is now powerfully driving the rapid pace of antimalarial drug discovery today.

Multiple Drug Resistance in Cancer 2 - Molecular, Cellular and Clinical Aspects (Hardcover, Reprinted from CYTECHNOLOGY,... Multiple Drug Resistance in Cancer 2 - Molecular, Cellular and Clinical Aspects (Hardcover, Reprinted from CYTECHNOLOGY, 27:1-3, 1998)
Martin Clynes
R5,678 Discovery Miles 56 780 Ships in 10 - 15 working days

Resistance to chemotherapy, and especially multi-drug resistance, represents a significant barrier to the successful treatment of cancer. This multi-author volume brings together a wide range of up-to-date reviews on different aspects of our knowledge of drug-resistance mechanisms, written by experts in the different areas. Particular attention is paid to recently discovered mechanisms relating to oncogene expression and in particular to proteins involved in regulation and execution of apoptosis. Other important topics covered include DNA repair, topoisomerases, cell cycle control, oxygenation and vascularisation of tumours, LRP, intermediate filament proteins and low-level resistance. Recent developments in understanding the role of efflux pumps (P-170, MRP) in multi-drug resistance are also reviewed. This book will be useful to clinicians and scientists working in the areas of chemotherapy, drug resistance, DNA repair and apoptosis research.

Matrix Metalloproteinase Inhibitors in Cancer Therapy (Hardcover, 2001 ed.): Neil J. Clendeninn, Krzysztof Appelt Matrix Metalloproteinase Inhibitors in Cancer Therapy (Hardcover, 2001 ed.)
Neil J. Clendeninn, Krzysztof Appelt
R4,385 Discovery Miles 43 850 Ships in 10 - 15 working days

Cutting-edge investigators review the current status of the entire field, from the biology of MMPs through the current clinical studies. The authors include many leading scientists from pharmaceutical companies who present all the latest concepts and results on the preferred design strategies for MMP inhibitors, their molecular mechanisms, and their substrates. In addition, they fully describe their personal research on specific MMP inhibitors, detailing vanguard design strategies, their in vitro activity, the outcome of animal model studies and, where available, their toxicology, safety, efficacy in human clinical trials.
Comprehensive and state-of-the-art, Matrix Metalloproteinase Inhibitors in Cancer Therapy offers basic and clinical investigators alike a richly informative summary of all the latest research on these powerful new drugs, and their high promise as emerging cancer therapeutics.

Kinesins and Cancer (Hardcover, 2015 ed.): Frank Kozielski, FSB Kinesins and Cancer (Hardcover, 2015 ed.)
Frank Kozielski, FSB
R4,780 R3,635 Discovery Miles 36 350 Save R1,145 (24%) Ships in 12 - 19 working days

This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development. Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future. The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.

Cancer Chemoprevention (Hardcover, 2001 ed.): Raymond C. Bergan Cancer Chemoprevention (Hardcover, 2001 ed.)
Raymond C. Bergan
R4,538 Discovery Miles 45 380 Ships in 10 - 15 working days

Great advances were made in the pharmacologic-based treatment of cancer in prior decades. However, despite a marked increase in our understanding ofcell and molecular mechanisms underlying the neoplastic process, therapy for advanced disease remains limited. While the reasons for this are many, it is generally accepted that advanced neoplasms contain a relatively large number of genetic and molecularalterations contributingto the maintenanceofthe neoplastic process. Such a situation precludes easy pharmacologic intervention. However, our ability to detect cancer at an earlier stage, coupled with our increased understandingofcarcinogenesis, are propellingboth basic and clinical scientiststo pursue early intervention/chemopreventive approaches. This is based upon the notion that fewer molecularaberrations are presentearlyon inthedisease process. It also takes advantage ofthe fact that advances in both technology, and in the field ofcancer biology, coupled with a heightened vigilance, have increased our ability to detect early disease more readily. The chemopreventive approach is highly attractive for a number ofreasons. First, treatment ofpre-neoplastic, or early neoplastic, lesions would prevent the significant mobility and mortality associated with advanced neoplastic disorders.

Brain Tumor - Research and Therapy (Hardcover): Masakatsu Nagai Brain Tumor - Research and Therapy (Hardcover)
Masakatsu Nagai
R1,644 Discovery Miles 16 440 Ships in 10 - 15 working days

The title of this monograph, Brain Tumor Research and Therapy, is the name of the Conference itself, which had its inaugural meeting in the United States in 1975 andhas since progressed to the international scale. In Japan, the first conference ofits kind was organized by Dr. Takao Hoshino and me and was held at Nikko in 1980, hence its name, the Nikko Conference on Brain Tumor Research and Therapy. Though it started as a small, closed meeting, the conference has grown considerably, and in 1992 it was reorganized as the Japanese Conference on Brain Tumor Research and Therapy and was opened to all neurosurgeons and neuropathologists interested in the study of brain tumor problems and who are participating in this field. The main purpose of the Conference on Brain Tumor Research and Therapy is the candid and informed discussion of the most up-to-date developments in basic re search and clinical treatment of brain tumors. The 3rd Japanese Conference on Brain Tumor Research and Therapy was held at Nasu (Tochigi Prefecture), Japan, in No vember 1994. It was a great honor to welcome many distinguished guests from over seas who kindly attended each session and made valuable contributions.

Microtubule Protocols (Hardcover, 2007 ed.): Jun Zhou Microtubule Protocols (Hardcover, 2007 ed.)
Jun Zhou
R2,910 Discovery Miles 29 100 Ships in 10 - 15 working days

This book presents a comprehensive collection of essential and up-to-date methods for studying both the biology of microtubules and the mechanisms of action of microtubule-interacting drugs. The book contains a straightforward presentation of readily reproducible protocols, tips for troubleshooting, and advice on avoiding common mistakes. Basic scientists and clinical researchers will benefit from this collection.

Cancer Therapeutics - Experimental and Clinical Agents (Hardcover, 1997 ed.): Beverly A. Teicher Cancer Therapeutics - Experimental and Clinical Agents (Hardcover, 1997 ed.)
Beverly A. Teicher
R5,689 Discovery Miles 56 890 Ships in 10 - 15 working days

Cancer drug discovery has been and continues to be a process of ingenuity, serendip ity, and dogged determination. In an effort to develop and discover better therapies against cancer, investigators all over the world have increased our knowledge of cell biology, biochemistry, and molecular biology. The goal has been to define therapeuti cally exploitable differences between normal and malignant cells. The result has been an increased understanding of cellular and whole-organism biology and an increased respect for the flexibility and resiliency ofbiologically systems. Thus, as some new therapeutic targets have been defined and new therapeutic strategies have been attempted, so have some new biological hurdles resulting from tumor evasion of the intended therapeutic attack been discovered. Historically, anticancer drugs have originated from all available chemical sources. Synthetic molecules from the chemical industry, especially dyestuffs and warfare agents, and natural products from plants, microbes, and fungi have all been potential sources of pharmaceuticals, including anticancer agents. There is no shortage of molecules; the challenge has been and continues to be methods of identifying molecules that have the potential to be therapeutically important in human malignant disease. "Screening" remains the most important and most controversial method in cancer drug discovery. In vitro screens have generally focused on cytotoxicity and have identified several highly cytotoxic molecules. Other endpoints available in vitro are inhibition of proliferation, 3 inhibition of [ H]thymidine incorporation into DNA and various viability assays, based most frequently on dye exclusion or metabolism.

Chemosensitivity - Volume I: In Vitro Assays (Hardcover, 2005 ed.): Rosalyn D Blumenthal Chemosensitivity - Volume I: In Vitro Assays (Hardcover, 2005 ed.)
Rosalyn D Blumenthal
R3,012 Discovery Miles 30 120 Ships in 10 - 15 working days

A state-of-the art collection of readily reproducible laboratory methods for assessing chemosensitivity in vitro and in vivo, and for assessing the parameters that modulate chemosensitivity in individual tumors. Chemosensitivity, Volume 1: In Vitro Assays provides a panel of 16 in vitro measures of chemosensitivity in adherent and non-adherent cells for single agents and combinations of agents. In addition to immunohistochemical and imaging approaches, these assays include clonogenic, colorimetric, fluorometric, and physiological assays. Highlights include image analysis to assess drug sensitivity, high throughput approaches using green fluorescent protein, DIMSCAN (a microcomputer fluorescence-based assay), and the ChemoFx assay used in biotechnology. A companion volume, Volume 2: In Vivo Models, Imaging, and Molecular Regulators, provides protocols for classifying tumors into response categories and customizing chemotherapy regimens to individual patients.

DNA Topoisomerases in Cancer Therapy - Present and Future (Hardcover, 2003 ed.): Toshiwo Andoh DNA Topoisomerases in Cancer Therapy - Present and Future (Hardcover, 2003 ed.)
Toshiwo Andoh
R2,890 Discovery Miles 28 900 Ships in 10 - 15 working days

This volume commemorates the 30th anniversary of the discovery in 1971 of the first DNA topoisomerases, i.e topoisomerase I in E. coli, then provisionally named omega' protein, by the pioneering work of Jim Wang at Harvard University, who has contributed an article to this volume: Reflections on an accidental discovery' of the enzyme. Many kinds of topoisomerase have since been found from type I through to type VI in a variety of organisms ranging from viruses to higher eukaryote mammals. The wide distribution of enzymes in various forms of life implies that the DNA topoisomerase is essential for life.

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

Cann's Principles of Molecular Virology (Paperback, 7th edition): Ed Rybicki Cann's Principles of Molecular Virology (Paperback, 7th edition)
Ed Rybicki
R2,459 R2,245 Discovery Miles 22 450 Save R214 (9%) Ships in 12 - 19 working days

Cann's Principles of Molecular Virology, Seventh Edition provides an easily accessible introduction to modern virology, presenting principles in a clear and concise manner. The new edition provides the history of virology and the fundamentals of the molecular basis of how viruses work. It discusses the interactions which control the structure of virus particles, the ways viruses infect cells, how viruses replicate themselves, and the consequences and pathogenesis of virus infection for host organisms. This fully updated edition also reflects advances made in the field and includes new content on phage therapy, CRISPR as a phage defense / offense system, new ideas about evolution, and giant viruses. With the addition of ancillary resources, Principles of Molecular Virology, Seventh Edition is an essential foundational reference for academics, graduate students, and advance undergraduates in virology, molecular biology, and microbiology as well as researchers entering virology, infectious disease, and immunology research.

Apoptosis and Cancer Chemotherapy (Hardcover, 1999 ed.): John A. Hickman, Caroline Dive Apoptosis and Cancer Chemotherapy (Hardcover, 1999 ed.)
John A. Hickman, Caroline Dive
R4,394 Discovery Miles 43 940 Ships in 10 - 15 working days

This collection of thoughtful and provocative articles focused on the key issues in apoptosis, ranges from the role of apoptosis in defining the response of authentic tumor populations to chemotherapeutic agents to the mechanisms coupling DNA damage to the activation pathway of apoptosis. It reviews the profusion of new signaling, modulating, and effector molecules now implicated in apoptosis and whether other routes to "programmed" cell death may exist. Also addressed are the nature of the molecules that will either constitute targets for future drugs or influence the efficacy of current therapies, as well as mechanistic questions on the control of apoptosis. By focusing on essential questions and critically summarizing the overwhelming tide of recent research results, Apoptosis and Cancer Chemotherapy illuminates not only the potential targets for tumor therapy, but beyond that, potential control points for cancer and such diverse diseases as viral infection, neurodegenerative disorders, and stroke. This collection of cutting-edge reviews by established leaders in the field critically summarizes the recent discoveries concerning apoptosis, cell suicide. The book looks forward to the time when such cell death can be controlled to treat cancer and a host of other diseases as diverse as viral infection, neurodegenerative disorders, and stroke.

Targets for Cancer Chemotherapy - Transcription Factors and Other Nuclear Proteins (Hardcover, 2002 ed.): Nicholas B. LA... Targets for Cancer Chemotherapy - Transcription Factors and Other Nuclear Proteins (Hardcover, 2002 ed.)
Nicholas B. LA Thangue, Lasantha R Bandara
R4,395 Discovery Miles 43 950 Ships in 10 - 15 working days

In Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins, a panel of leading basic researchers, pharmaceutical scientists, and clinical oncologists explain in detail the therapeutically-relevant protein targets that contribute to cancer pathology and spell out their implications for cancer drug discovery and clinical application. The authors identify and illuminate selected transcription factor oncoproteins and tumor suppressors, together with nuclear proteins that are central to the phenotype of the tumor cell involved in chromatin control. The emphasis is on new targets and approaches to cancer treatment derived from the cancer cell cycle, gene control targets, and angiogenesis.

Practical Chemotherapy - A Multidisciplinary Guide - A multidisciplinary guide (Paperback, 1 New Ed): Maxwell Summerhayes,... Practical Chemotherapy - A Multidisciplinary Guide - A multidisciplinary guide (Paperback, 1 New Ed)
Maxwell Summerhayes, Susanna Daniels
R1,998 Discovery Miles 19 980 Ships in 12 - 19 working days

The growth in chemotherapy has led to a great need for all those involved to be familiar with safe procedures based on best evidence-based practice. Practical Chemotherapy: a multidisciplinary guide is a comprehensive and straightforward guide describing over 70 widely used chemotherapy regimens, helping to make their prescription and administration safer and less problematic. Checklists throughout the book are specifically tailored for the needs of each professional group involved in treatment, and are intended to help prevent potentially serious mistakes that can occur. This book is unique in its practical emphasis and will be invaluable for doctors, pharmacists and nurses working in oncology and haematology.

Cytokines: Interleukins and Their Receptors (Hardcover, 1995 ed.): Razelle Kurzrock, Moshe Talpaz Cytokines: Interleukins and Their Receptors (Hardcover, 1995 ed.)
Razelle Kurzrock, Moshe Talpaz
R8,514 Discovery Miles 85 140 Ships in 10 - 15 working days

Over the last decade, cytokine research has emerged as one of the most exciting and critical fields for providing fundamental knowledge of normal and abnormal human development. Today, it is apparent that cytokines orchestrate growth from the early embryonic stage to maturity and are responsible for the normal function of virtually every organ system. Furthermore, virtually all disease states have been associated, at least in part, with cytokine aberrations. In this volume, the editors have brought together internationally known experts in the field of interleukin research to provide a comprehensive review of the biology of the interleukins and their role in both health and illness, while maintaining a balance between the basic science and clinical aspects. Cytokines: Interleukins and their Receptors should be of interest to a wide variety of researchers including clinical hematologists, oncologists, immunologists, in addition to medical and PhD students and researchers with an interest in cytokines.

Anticancer Drug Resistance - Advances in Molecular and Clinical Research (Hardcover, 1994 ed.): Lori J. Goldstein, Robert F.... Anticancer Drug Resistance - Advances in Molecular and Clinical Research (Hardcover, 1994 ed.)
Lori J. Goldstein, Robert F. Ozols
R5,624 Discovery Miles 56 240 Ships in 10 - 15 working days

Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease. We are still, however, confronted with over 500,000 cancer-related deaths per year. Clearly, the phenomenon of drug resistance is largely responsible for these failures and continues to be an area of active investigation. Since the last volume in this series, we have learned that the energy-dependent drug efflux protein, p-glycoprotein, encoded by the MDR 1 gene, is a member of a family of structurally related transport polypeptides, thus allowing us to explore the relationship between structure and function. In addition to ongoing well designed clinical trials aimed at reversing MDR mediated drug resistance, the first gene therapy studies with the MDR 1 gene retrovirally transduced into human bone marrow cells are about to be initiated. Although MDR is currently the most understood mechanism of drug resistance, we are uncovering increasing knowledge of alternative molecular and biochemical mechanisms of drug resistance to antimetabolites, cisplatin and alkylating agents and developing new strategies for circumventing such resistance. It is clear that drug resistance is complex, and many mechanisms exist by which cancer cells may overcome the cytotoxicity of our known chemotherapeutic agents. As our understanding of each of these mechanisms expands, well designed models will be necessary to test laboratory hypotheses and determine their relationship to drug resistance in humans. It is this integration of basic science and clinical investigation that will both advance our scientific knowledge and result in the improvement of cancer therapy.

Chemotherapy Regimens and Cancer Care (Paperback, illustrated edition): Alan D. Langerak Chemotherapy Regimens and Cancer Care (Paperback, illustrated edition)
Alan D. Langerak
R1,605 Discovery Miles 16 050 Ships in 12 - 19 working days

This handbook is a concise, thorough, and portable reference guide to the multitude of complex chemotherapy protocols and other frequently utilized medications in the field of Hematology/Oncology. Its inclusion of commonly used oncology regimens, guidelines for supportive care during administration and sections on pain control, antibiotic use and antiemesis guidelines set it apart from other "chemotherapy handbooks". The authors have prepared this book with the intention of improving the care of those suffering from cancer.

Farnesyltransferase Inhibitors in Cancer Therapy (Hardcover, 2001 ed.): Said M. Sebti, Andrew D. Hamilton Farnesyltransferase Inhibitors in Cancer Therapy (Hardcover, 2001 ed.)
Said M. Sebti, Andrew D. Hamilton
R4,597 Discovery Miles 45 970 Ships in 10 - 15 working days

Cutting-edge researchers describe their efforts to design, synthesize, and evaluate the biological activities of farensyltransferase inhibitors (FTIs); geranylgeranyltransferase inhibitors (GGTIs) are also discussed as potential anticancer drugs. The authors survey in detail such inhibitors as CAAX box peptidomimetics, FPP mimics, and bisubstrate transition state analogs, and critically review their uses in combination with radiation and other cytotoxic agents, such as gemcitabine, cisplatin, and taxanes. Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.

Regional Chemotherapy - Clinical Research and Practice (Hardcover, 2000 ed.): Maurie Markman Regional Chemotherapy - Clinical Research and Practice (Hardcover, 2000 ed.)
Maurie Markman
R4,666 Discovery Miles 46 660 Ships in 10 - 15 working days

Maurie Markman and a panel of distinguished clinicians and leading clinical investigators comprehensively review the current status of regional antineoplastic drug delivery in the management of malignant disease. These authorities present a critical analysis of both the rationale and limitations of regional therapy and discuss potential clinical trials designed to explain the effectiveness of this method of therapy in special settings. Their presentations describe many exciting and innovative strategies for using regional drug delivery in anticancer therapy, including coverage of such areas of special interest as colorectal, skin, lung, pancreatic, ovarian, and gastrointestinal cancers. Comprehensive and authoritative, Regional Chemotherapy: Clinical Research and Practice offers surgical and medical oncologists and clinical cancer investigators a gold-standard review of the current role and future development of this increasingly powerful weapon in the battle against cancer.

Medical Management of Cancer-treatment Induced Emesis (Hardcover): M. Dicato Medical Management of Cancer-treatment Induced Emesis (Hardcover)
M. Dicato
R3,600 Discovery Miles 36 000 Ships in 12 - 19 working days

Nausea and vomiting are two of the most common side-effects of anti-cancer treatment, and the discovery and clinical application of 5-hydroxytryptamine3 receptor antagonists has transformed the management of these side effects, resulting in a much improved quality of life for cancer patients. This text presents a detailed overview of the management of cancer-treatment induced emesis in a number of different treatment settings, and focuses on the mechanisms and use of 5-HT3 receptor antagonists. Contributions are also included from the points of view of the nurse and the patient.

Cytokines in the Genesis and Treatment of Cancer (Hardcover, 2007 ed.): Michael A. Caligiuri, Michael T. Lotze Cytokines in the Genesis and Treatment of Cancer (Hardcover, 2007 ed.)
Michael A. Caligiuri, Michael T. Lotze
R5,711 Discovery Miles 57 110 Ships in 10 - 15 working days

Cytokines in the Genesis and Treatment of Cancer provides a comprehensive picture of the dual role of host responses in promoting and inhibiting tumor progression. This volume represents an important investigation into the emerging intersection of cancer biology and cancer immunology. The book brings together an impressive array of internationally distinguished investigators who are devoted to the study of cytokines and cancer.

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models - Proceedings of the Second Drug Discovery... Anticancer Drug Discovery and Development: Natural Products and New Molecular Models - Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA - June 27-29, 1991 (Hardcover, 1994 ed.)
Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker
R8,524 Discovery Miles 85 240 Ships in 10 - 15 working days

With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer. This Second Symposium emphasized the types of materials being discovered and their therapeutic activity. This is especially evident in the natural product discovery programs, where unique and active structures are being identified. The major contributors to the meeting were the investigators participating in the National Cooperative (Natural Products) Drug Discovery Groups [NC(NP)DDG]. These groups reflect an association among researchers at universities or cancer centers, pharmaceutical companies and the National Cancer Institute. Their sources of materials are varied, reflecting chemical inventories of pharmaceutical companies, organic synthetic compounds from the laboratory, cytotoxics as well as biologics and their hybrids, and natural products obtained from plants, marine organisms and microorganisms. The models employed in the discovery systems vary from broadly cellular based to specific enzymes to defined cellular functions. Each of them is believed important to the malignant state and will allow for the discovery of compounds which will have efficacy in cancer therapy. The goal of the participants is both to discover new anticancer agents and to develop them as efficiently as possible into clinically useful additions to treatment. Of importance is the fact that there are a number of promising leads which will soon be moving into the clinic thereby testing the effectiveness of this NC (NP) DDG approach.

Cancer Doctor (Hardcover): Barth Hoogstraten Cancer Doctor (Hardcover)
Barth Hoogstraten
R539 Discovery Miles 5 390 Ships in 12 - 19 working days

Students and house staff officers are lucky when one of their professors takes the time to discuss with them how he/she tells a bad diagnosis to a new patient. This is how I advise them to handle it: 'Take a chair or sit on the edge of the bed if need be and touch a hand. That will comfort the patient. And don't think for a minute that men do not appreciate that gesture; they do. Unless the patient decides differently, it is better when the spouse, a close member of the family or a friend is present. Remember that after you leave the room, it will be awfully lonely for the patient. Tell the bad news, but immediately hold out a few rays of hope to grasp. And be prepared to answer the questions that will follow, not once but several times because most patients do not remember what you told them. You will be amazed how the well-informed patients accept the worst diagnosis and how grateful they are that you took the time to sit with them. Answer all questions and remember, the informed patient becomes your best patient. And no question is a dumb question.'

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Mechanics Of Materials - SI Edition
Barry Goodno, James Gere Paperback R1,464 R1,359 Discovery Miles 13 590
Risk and Return in Asian Emerging…
N. Cakici, K. Topyan Hardcover R2,369 R1,923 Discovery Miles 19 230
Smart Sensors and MEMS - Intelligent…
S. Nihtianov, A. Luque Paperback R6,688 R6,173 Discovery Miles 61 730
Combined Transport Documents - A…
John Richardson Hardcover R5,570 Discovery Miles 55 700
Beginning Ubuntu Linux - From Novice to…
Keir Thomas Mixed media product R1,141 R1,002 Discovery Miles 10 020
Linux for Hackers - A Comprehensive…
William Vance Hardcover R625 R568 Discovery Miles 5 680
Sudo Mastery
Michael W Lucas Hardcover R963 R868 Discovery Miles 8 680
The Definitive Guide to Linux Network…
Nathan Yocom, John Turner, … Paperback R1,656 R1,354 Discovery Miles 13 540
Obshchestvennost' and Civic Agency in…
Yasuhiro Matsui Hardcover R2,133 R1,945 Discovery Miles 19 450
The Science and Practice of Middle and…
Richard Blagrove, Philip Hayes Paperback R1,461 Discovery Miles 14 610

 

Partners